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1. Introduction
In the human body, an organ is a composite of different tissues in an ordered structural unit
to serve a common function [1]. Ordinarily, cells self-assemble into tissues before forming an
organ. There are at least three different tissues in a complex organ, such as the liver, heart,
and kidney. Currently, complex organ failures are the first cause of mortality in developed
countries despite advances in pharmacological, interventional, and surgical therapies [2].
Orthotopic organ transplantation is severely limited by the problems of donor shortage and
immune rejections [3]. Extracorporeal support systems perform some specific functions
within a limited time period [4]. Cell encapsulation techniques face the problems of capsule
loss, low stability, and poor efficiency [5]. Cell sheet technique cannot rescue tissues with in‐
creased thicknesses above 80 µm [6]. Decellularized matrices are hard to be repopulated by
multiple cell types [7]. On the other hand, stem cell research has emerged as one of the most
high-profile and promising areas of 21st century science [8-10]. Typically, autologous adi‐
pose-derived stem cells (ADSCs) represent one of the most abundant, easily cultured, rapid‐
ly expanded, and multipotent cell source [11]. It has been a long-term goal in this field to
manufacture complex organs from biocompatible materials (including non-immune patient
derived cells) and computer-aided design (CAD) models in a fast, easy, cheap and automat‐
ic manner.
To manufacture a complex organ, cells act like building blocks and have special functions. A
comprehensive multidisciplinary effort from biology, implantable biomaterials, and rapid
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prototyping (RP) technology is extraordinarily needed. A biomaterial is defined as any mat‐
ter, surface, or construct that interacts with biological systems [12]. It may be an autograft,
allograft or xenograft transplant material, or a nature derived or laboratory synthesized
chemical component. Biomaterials are often used and/or adapted for a medical application,
and thus comprise whole or part of a living structure or biomedical device which performs,
augments, or replaces a natural function [13]. RP, also referred to as additive manufacturing
(AM) or solid freeform fabrication (SFF), is a set of manufacturing processes which can de‐
posit materials layer-by-layer until a CAD model with freeform geometry has been built. RP
technology, which has been widely used in the automatic fabrication of complex geometric
structure areas, carries the promise to become the most convenient and reliable technique
for manufacturing of complex organs in the coming years [14-18].
Over the last two decades, tissue-engineering researchers have devoted themselves to seed‐
ing cells onto a porous biodegradable scaffold material to direct cell differentiation and
functional assembly into three-dimensional (3D) tissues [19]. This strategy has achieved a
great success in simple tissue/organ regeneration [20]. However, it is extremely difficult for
this strategy to be used in creating a branched vascular system or a complex organ regenera‐
tive template mimicking the native ones with similar mechanical and biological properties.
Similar to building a nuclear power plant for complex organ manufacturing, there is a sig‐
nificant gap between simple tissue/organ engineering and complex organ manufacturing
approaches both in fabrication technique employed and ultimate goal achieved (Table 1)
[14-18].
Complex organ manufacturing Nuclear power plant building
Cells Bricks, nuclear reactors
Synthetic, natural polymers Steel
Crosslinking agents Cements
Vascular systems Water and light pipes
Nerve system Electric control system
Multi-nozzle rapid prototyping machines Cranes
CAD models Blueprints
Construction Architecture
Table 1. Analogues between complex organ manufacturing and nuclear power plant building.
The ultimate goal of complex organ manufacturing is to fabricate hybrid biomaterial (in‐
cluding living cells, even gene/protein) structures over a range of size scales (i.e. from a few
micrometers to a few millimeters). We herein provide insights into some special integrations
of biomaterials and RP techniques towards the purpose of intelligent freeform manufactur‐
ing of complex organs. The most successful and promising integrations have been highlight‐
ed; meanwhile the future development directions have been highlighted.
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2. Biomaterials and RP techniques in thousands of postures
As stated above, biomaterials, usually acting as synthetic frameworks (referred as scaffolds,
matrices, or constructs), can be categorized into different groups according to their supply
sources, existence states, chemical properties as well as biomedical applications. Typically,
patient specific blood, cells (especially stem cells), acellular matrices, tissues and organs are
a kind of biomaterials with no immune reactions. More than 100 implantable biomaterials
have been reported in different forms, such as bulks, blocks, membranes, sheets, beads, hy‐
drogels, fibers, sutures, plates, nets, meshs, tubes, non-woven fabrics, porous scaffolds (or
sponges), heart valves, intraocular lenses, dental implants, pacemakers, biosensors, etc
[21-23]. However, very few of them are suitable for complex organ manufacturing purposes.
For biomedical applications, biocompatibility, biodegradability and processing ability are
among the most crucial issues one should consider. In most cases the implantable biomateri‐
al has to be nontoxic, biocompatible, and biodegradable. Therefore, stringent criteria must
be met before proceeding to clinical applications.
Especially, hydrogels are a family of natural or synthetic polymers with high water contents.
During the last twenty years, hydrogels have been an important class of soft tissue repair
materials or cell delivering vehicles that can be fabricated in the form of 3D micro-periodic
structures by colloidal templating [24], interference lithography [25], direct-writing [26], ink-
jet printing [27], and two-photon polymerization (2PP) [28].
In the last four decades, significant advances have been made in the progress of scaffold fab‐
rication techniques for biomedical applications. For example, synthetic and natural biode‐
gradable polymers, such as polylactic acid (PLA) [29], poly(lactic/glycolic) acid (PLGA) [30],
collagen [31], hyaluronic acid [32] and chitosan [33], are often used as pure implantable bio‐
materials or tissue engineering scaffolds.
In parallel with the development of biomaterials, the number of commercial RP techniques
has expanded rapidly during the last decade. More than 30 different RP techniques have
been applied in the most diverse industries. Several companies are now using RP technolo‐
gies for plastic, wood and metal product manufacturing. For example, Siemens, Phonak Wi‐
dex, and other hearing aid manufactures use selective laser sintering (SLS) techniques to
produce hearing aid shells. Align technology uses SLS techniques to fabricate molds for pro‐
ducing clear braces (“aligners”). And Boeing and its suppliers use SLS techniques to pro‐
duce ducts and similar parts for F-18 fighter jets [34]. Around 20 of the RP techniques have
been adapted in the field of regenerative medicine [35]. Basically, these adaptations can be
classified into three major groups hinged on the RP working principles (Figure 1): (i) nozzle-
based extruding/assembling/deposition systems, e.g. fused deposition modeling (FDM) (Fig‐
ure 1A) [36], pressure assisted manufacturing (PAM), low-temperature deposition
manufacturing (LDM), and bio-plotters (3DB) (Figure 1B) [37,38], which deposit materials
either thermally or chemically through pens/syringes/nozzles; (ii) laser/photolithography-
based writing systems, e.g. laser-guided direct writing, which arrange meterials/cells by la‐
ser beams [39,40] or photopolymerize a liquid (resin, powder, or wax) in stereolithography
(SLA or STL) (Figure 1C) [36,41], or sinter powdered material in SLS systems (Figure 1D)
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[42]; (iii) printing-based inkjeting systems, e.g. 3D printing (3DP) systems and wax-based
systems, which print a chemical binder onto a powder bed and print two types of wax mate‐
rials in sequence (Figure 1 E) [36].
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Figure 1. Working principles of various rapid prototyping systems: A) Schematic illustration of the nozzle-based FDM
process [36]. B) Scheme of a nozzle-based 3D-Bioplotter heated cartridge setup [37,38]. C) Schematic of the laser-
based SLS techniques [36]. D) Schemes of two laser-based of stereolithography (SLA or STL) setups [39]. Upper: a bot‐
tom-up system whereby the laser scans the surface for the curing of the photosensitive materials. Bottom: a top-down
setup with dynamic digital light projection to cure a complete 2D layer at once. E) Schematic of the 3DP systems [36].
Although most of the adapted techniques can be used in building complex geometrical shapes
with CAD modelling, every technique group is subjected to a limited biomaterial incorpora‐
tion ability and has its own drawbacks in creating 3D living organs. For example, Chu and
coworkers have developed design-for-manufacturing rules for their lattice mesostructure fab‐
rication technique with a STL system. Lattice structures tend to have geometry variations in
three dimensions [43]. However, this system is not fully capable of creating a branched vascu‐
lar system, which is vitally important in the context of organ manufacturing to direct spatially
heterogeneous tissue development. On the other hand, Arcaute and coworkers have encapsu‐
lated human dermal fibroblasts in a synthetic poly(ethylene glycol)-dimethacrylate hydrogel
by a SLA technique. Without porous structures and biodegradable properties of the synthetic
polymers, it is hard for the cells to form tissues inside the hydrogel [44]. The integrations of bi‐
omaterials and RP techniques can form a huge “family tree” with many different combina‐
tions. Figure 2 summarizes the integrations of biomaterials with RP techniques and their
potential usages in complex organ manufacturing.
Currently, as the concepts of “factory in a box” and “desktop manufacturing” are expand‐
ing, new applications of RP techniques in architectural design and 3D construct building in‐
crease speedily. Among the most popular RP techniques, the Fab@Home equipments with
an average price of about 3000 US dollars are among the most convenient and cost effective
RP instruments used in biomaterial fabrication field [45].
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Figure 2. A “family tree” indicates various integrations of biomaterials and rapid prototyping techniques.
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At present, the concepts of “scaffolds”, “tissues”, and “organs” are rather confused both in
scientific and industrial areas. Most researchers and manufacturers in the area of tissue engi‐
neering like to label their RP products as “scaffolds”, “tissues”, or “organs”. It is reasonable
to describe an accellular porous 3D structure with a micro-scale internal architecture but
without cells as a “scaffold”. However, those with living cells incorporated should be de‐
fined as “constructs”. Especially, those with cells have already connected to each other to
perform special functions should be called “tissues”. As described in the beginning of the
introduction section, those with more than three different tissue types inside a construct
should be called “organs”. Simple organs, such as the bladder and blood vessels, should
have less than or equal to three tissue types, while complex organs, such as the liver, heart,
and kidney, should posses more than three tissue types. With these definitions, it is easier to
distinguish which RP technique will be useful in complex organ manufacturing.
3. The integrations of biomaterials with RP techniques for complex organ
manufacturing
The ability to put material only into a specific location where it is desired could have a pro‐
found impact on how parts are designed and manufactured [46]. Similarly, the ability to put
different biomaterials (including different cell types) to exact sites where they are desired
could have a profound impact on how complex organs are designed and manufactured. For
example, in a complex organ, such as the liver, at least three different cell types (hepato‐
cytes, stellate cells, and Kupffer cells) are required that function in a construct along with the
three common cell types of a vascular system. The fundamental unit of the liver, the acinus,
has a typical radius of 500 µm. Within this structure at least six cell types interact with one
another to coordinate the diversity of liver functions [46]. The spatially heterogeneous ar‐
rangements of multi-tissues make all the traditional, or existing techniques incapable of
completing this ambitious task.
Over the last ten years, the integration of biomaterials with RP techniques in creating special
3D constructs for various biomedical applications has emerged. The ability to use data from
clinical imaging techniques like magnetic resonance imaging (MRI), computerized tomogra‐
phy (CT) or patient-specific data makes RP techniques particularly useful for biomedical ap‐
plications. Several research groups have adapted different RP techniques to assemble (or
print) cell-laden constructs directly from computer-programmed design models with high
resolution (Table 2) [47-64]. Six unique intelligent RP devices as well as their primary prod‐
ucts are shown in Figure 3[47-52, 65-67]. These processes have demonstrated some possibili‐
ties in the area of complex organ manufacturing. The pros and cons of these techniques in
complex organ manufacturing are outlined in Table 2. Those with only porous 3D scaffolds
are not included here because these integrations have been reported extensively in the for‐
mer reviews [36,37,44,68-79].
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Technique Pros Cons Refs
3D inkjet bioprinting
(3DP) in and
Pittsburgh Clemson
University, USA
Several thermosensitive hydrogels
can be used as biopaper; low
viscosity cell suspensions or
aggregates can be used as bioink;
Cell viability greater than 85%.
Complex 3D constructs are difficult to
realize; limited feature height (< 5 µm);
lack of structural support for cell layer or
cell aggregates; tissue formation into lines
depends on cell or cell aggregate fusion or
assembling; poor mechanical properties.
[47, 48]
3D direct-write
bioprinting in
University of Cornell
and Arizona, USA.
Low and high viscosity hydrogels,
including type 1 collagen and
alginate can be used; high cell
viability (up to 98%); flexible
geometric shapes.
Cell viability depends largely on the inner
diameter of the gauge tip, collagen
concentration and extraction
environments; difficult to control the
collage gel state.
[49, 50]
3D fiber deposition
(3DF) in University
Medical Center
Utrecht, The
Netherlands.
High viscosity hydrogels, such as
Pluronic F127, Matrigel, alginate and
agarose, can be used; multiple cell
types can be incorporated;
homogeneous and heterogeneous
structures can be created.
Limited materials can be used; limited
height of 3D construct (< 10 µm); difficult
cell-cell interactions; poor mechanical
properties.
[51, 52]
3D single/double
syringe cell
assembling (or
pressure assisted
manufacturing
(PAM)) in Tsinghua
University, China.
Gelatin-based hydrogels can be
used; a wide range of biological
components can be incorporated;
variable and hybrid geometric
shapes; high cell viability (more than
98%); easy for long-term storage
and transportation.
Limited materials can be used; weaker
mechanical properties.
[53 - 60]
Double-nozzle low-
temperature
deposition
manufacturing
(DLDM) in Tsinghua
University, China.
A wide range of biomaterials
including both synthetic and natural
polymers can be used; a wide range
of biological components can be
incorporated; arbitrarily hybrid
geometric shapes; high mechanical
properties; easy for long-term
storage and transportation.
Material viscosity and temperature
dependent.
[61 - 64]
Table 2. Comparison of different cell-laden rapid prototyping techniques in complex organ manufacturing
Due to the heterogeneous properties of complex organs both in geometrical structures and
material components, emphases should be given to those RP techniques with further devel‐
opment possibilities in the further integrations of biomaterials and equipments. In the fol‐
lowing part of this section, some special two or multiple syringe/nozzle techniques are
highlighted. In Harvard Medical School, Lee and coworkers have printed a collagen hydro‐
gel precursor, fibroblasts and keratinocytes into a quasi 3D structure for skin repair using a
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robotic platform (Figure 3D) [65]. The procedure involves printing a layer of liquid collagen
to act as a hydrogel precursor. The liquid collagen is crosslinked with a nebulized aqueous
crosslinking agent (sodium bicarbonate) to form a hydrogel that provides structural integri‐
ty for the subsequent cell suspensions. In fact, this technique is an extension of the above
mentioned 3DP or 3DB robotic system with additional syringes as “cartridges” to load two
cell suspensions and hydrogel precursors. Highly viable proliferation of each cell layer (85%
for keratinocytes and 95% for fibroblasts) was observed on both planar and non-planar sur‐
faces. For thin tissue/organ (such as skin/bladder) manufacturing, this technique is a right
choice. However, for complex organ manufacturing, some intrinsic shortcomings, such as
limited printing height, and difficult to control the collagen gelation process, made this tech‐
nique almost incapable.
In University Medical Center Utrecht, The Netherlands, Prof. J Alblas’s group, a special bio‐
scaffolder pneumatic dispensing system (SYS + ENG) was adapted for printing cell-laden
bone tissue repair hydrogels. High viscosity alginate (10% w/v) and BD MatrigelTM (10%
w/v) hydrogels were employed. A limited ten-layer rectangular 3D construct of 10 ×10 mm
with spacing between fibers of 0.8-2.5 mm and a thickness of 100 µm was fabricated and
subsequently crosslinked in a CaCI2 solution [51]. In spite of the limited height, the intercon‐
nected channels are still necessary for oxygen and nutrient delivery, as well as for tissue for‐
mation and vascular ingrowth. There are two critical drawbacks of this technique in
complex organ manufacturing. The first is the poor mechanical properties of the cell-laden
alginate or matrigel hydrogel for use as vascular systems. The second is that low viscosity
hydrogels (including alginate and matrigel) are hard to be assembled into 3D constructs.
In university of Missouri, Norotte and coworkers used agarose rods as a molding template
to print multicellular spheroids with their special bioprinter to form a tubular cell-laden
structure (Figure 3E) [66]. After the fabrication stage, they manually pulled the agarose rods
out of the tube, and concluded that it is a time consuming and labor-/spheroid- intensive
procedure.
4. Some outstanding achievements made in Tsinghua University
In parallel with the above mentioned RP approaches, a series of RP technologies have been
explored extensively by Professor XH Wang’s group at the Center of Organ Manufacturing,
Department of Mechanical Engineering, Tsinghua University, China. State-of-the-art of the
layer-by-layer modeling, material incorporation, and manufacturing principles of these tech‐
niques can be found in some of the pertaining references. The advantages and disadvantag‐
es of these approaches to be used in complex organ manufacturing have also been listed in
Table 2. Previous studies have demonstrated their abilities to engineer complex 3D tissues
using various single/double nozzle/syringe RP systems. In the following section some tech‐
nical specifications are highlighted.
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 Figure 3. Several unique intelligent rapid prototyping devices and their functional cell-laden products: A) The inkjet
cell printer and its bagel-like quasi-3D structure developed in Clemson University, prof. T Boland’s group [47]. B) The
robotic printing platform and its crescent construct made in Cornell University, prof. LJ Bonassar’s group [49]. C) The
direct-write system and its preliminary 3D figures developed in University of Arizona, prof. SK Williams’ group [50]. D)
A modular tissue printing platform with 4 ‘cartridges’ to load cell suspensions and hydrogel precursors developed in
Brigham and Women’s Hospital, Harvard Medical School, Prof. S.-S. Yoo’s group [65]. E) A bioprinting tubular struc‐
ture with cellular cylinders developed in University of Missouri, Columbia, USA, Prof. G Forgacs’ group [66]. F) A laser-
guided direct writing (LGDW) system and its patterned factor-linked beads on a stem cell monolayer with micrometer
accuracy (Bar = 200 μm) developed in University of Minnesota, prof. D.J. Odde’s group [67].
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4.1. The single syringe cell assembling technique
Figure 4 shows some of the cell assembling results using our first generation cell assembling
system. A gelatin based hydrogel system, such as gelatin, gelatin/chitosan, gelatin/hyaluron‐
an, gelatin/alginate, gelatin/fibrinogen or gelatin/alginate/fibrinogen, was integrated with a
single syringe cell-assembling machine to obtain the necessary space and stabilizing factors for
cell survival and tissue formation [53-58]. A single cell type was deposited at an ambient tem‐
perature (1~10℃) layer by layer in a chamber as the sol state material was transferred into a hy‐
drogel. Grid hepatic tissues, endodermis, and adipose tissues have been regenerated by using
this single syringe cell-assembly machine at about 8℃. The gelatin based hydrogel network
provided stabilization support for the 3D constructs during the fabrication and post culture
stages. This mild deposition temperature is favorable for biological property preservation as
increased Joule heating can result in loss of cell viabilities and bioactivities. During the culture
period, the gelatin based hydrogel served as both a mass transportation template for tissue de‐
velopment and an extracellular matrix accommodation mimicking the microenvironment in
native organs. The use of the natural gelatin based hydrogels was clearly highlighted the dis‐
tinct advantage of this cell assembly technique for fabricating living tissue analogs. A shortage
of the single nozzle/syringe systems was that, these systems lack the ability to easily create
parts with spatial heterogeneous materials. Consequently, two double nozzle/syringe RP sys‐
tems have been explored to deposit different materials at different temperatures.
Figure 4. Hepatocyte and adipose-derived stem cell (ADSC) assembling based on the first generation of cell assem‐
bling technique developed in Tsinghua University, prof. XH Wang’ group [53-58]
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4.2. The double syringe cell assembling technique
Different from the above single syringe cell assembling technique, a double syringe cell assem‐
bling technique was developed in Tsinghua Unversity with a updated software and hard‐
ware. Gradient and cylindrical architectures consist of two different cell-laden hydrogels have
been fabricated at a temperature range of 8 – 10℃ [59,60]. Two cell lines encapsulated in the
similar gelatin-based hydrogels were put into different regions or compartment in a construct
(Figure 5). The embedded branched networks enable culture medium to flow through the en‐
tire construct with unparalleled geometric complexity. However, there is a fatal shortcoming
of this system to be used in complex organ manufacturing. The mechanical weak properties of
the gelatin-based hydrogel made it impossible to connect the branched construct to an in vivo
vascular system to endure anti-suture anastomosis and blood pressure even after a long-term
in vitro culture period.
Figure 5. Cell assembling based on a two syringe RP technique developed in Tsinghua University, prof. XH Wang’
group. Two different cell types in the gelatin-based hydrogels can be assembled simultaneously into a construct
[59-60].
4.3. The combination of cell assembly and cryopreservation techniques
With the advantages of the gelatin-based hydrogel, cryoprotectants (e.g. dimethyl sulfoxide
(DMSO), glycerol, and dextran-40) can be incorporated into the cell/hydrogel system and the
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constructs can be stored at low temperature (below -80℃) directly after the fabrication stage
(Figure 6). This incorporation technique represents a significant advancement towards the
cell-laden product storage and transport, potentially resulting in labor and resource saving,
clinical availability and medical convenience [80-82]. With the gelatin-based hydrogel vari‐
ous bio-factors including macromolecular cell growth factors, small chemical regulators, and
even genes/drugs can be easily incorporated to the deposition or assembling systems. This
approach is suitable for some special natural thermosetting polymers’ (e.g. gelatin and agar‐
ose) deposition and opens a new avenue for complex organ manufacturing.
Figure 6. The combination of cell assembly and cryopreservation techniques, developed in prof. XH Wang’ group
[80-82].
4.4. The double-nozzle low-temperature deposition manufacturing (DLDM) system
The creation of a geometrically complex branched vascular system is a subject of broad fun‐
damental and technological interest in complex organ manufacturing. With the DLDM sys‐
tem it is easy to deposit two different material systems, especially both synthetic and natural
polymer systems simultaneously in a construct (Figure 7). Grid, tubular and elliptic struc‐
tures with both synthetic and natural polymers, such as PU/gelatin and PU/collagen, have
been produced at a low-temperature range of -20 - -30 ℃ [61-64]. As shown in Figure 7C, PU
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and collagen were successfully assembled into a tubular double layer construct. In Figure
7D, an elliptic hybrid hierarchical PU-cell/hydrogel construct with branched and grid inter‐
nal channels was realized. Cells can survival the heterogeneous fabrication, polymerization/
crosslinking, and even storage stages with a high recovery proliferation ability. Figure 7D
demonstrates that the external out coat was made of a PU/tetraglycol solution to provide
mechanical support for the whole construct. The internal branched and grid channels were
made of a cell/dimethyl sulfoxide (DMSO) containing gelatin/alginate/fibrinogen hydrogel
to encapsulate ADSCs. Both the out coat PU and compartment cell/hydrogel layers possess
microporous, which permit water, oxygen and other small molecules to pass. During the
fabrication stage, a low temperature in the range of -20 - -30 ℃ around the nozzles is an im‐
portant factor to control the sol-gel transformation of the material systems. If the tempera‐
ture is set too high, the deposited fiber (strand) cannot solidify to form a stable 3D structure.
On the other hand, if the temperature is set too low, the fiber is frozen too quickly to fuse
with the previous deposited layer. An optimum deposition temperature has played a central
role in putting the heterogeneous material systems at the desired locations in the construct.
Figure 7. A DLDM technique developed in Tsinghua University, prof. XH Wang’ group. An elliptical hybrid hierarchical
polyurethane and cell/hydrogel construct was fabricated using the DLDM system [61-64].
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This DLDM technique has demonstrated some outstanding merits in complex organ manu‐
facturing with two different material systems that are technologically and biologically inca‐
pable to produce using the other existing or traditional RP techniques. The potential
applications of the assembled elliptic hybrid hierarchical constructs are diverse, such as cell-
cell interaction analyses, stem cell differentiation tracing (pursuing), chemical drug screen‐
ing, and pathogenic mechanism studies. The synthetic PU system can provide elaborate
compartments for cell/hydrogel accommodation. In these compartments, the composition of
the cell/hydrogel mixture becomes the key factor in ensuring spatially uniform cell distribu‐
tion, survival, proliferation and differentiation. By encapsulating the cell/hydrogel mixture
in the PU compartments, the composition and proportion of hydrogel components can be
easily adjusted to meet the necessary requirements for mimicking the natural cellular ar‐
rangements. A maximal cell density (hydrogel-poor and cell-rich) can be easily achieved in
the compartment. The use of gelatin-based hydrogel can even be avoided completely in this
system, irrespective of stabilization of the construct. Compared with the pure cell/gelatin/
alginate/fibrin construct made by the single/double RP systems, the hybrid hierarchical net‐
work can provide much higher mechanical stability and pressure resistance abilities when it
is applied to in vitro pulsatile cultures and in vivo blood vessel anastomoses. Some experi‐
ments have proved that the 3D constructs with intrinsic interconnected branched and grid
channels were easily adapted to an in vitro pulsatile culture and in vivo implantation system
[83-86].
5. A four-nozzle low-temperature deposition manufacturing (FLDM)
system
At present, a FLDM system is under development in professor XH Wang’s group [18]. Fig‐
ure 8 demonstrates the outlook of the machine and a primary try on a liver lobe like struc‐
ture construction. Compared with the DLDM RP system, two more nozzles have been
equipped. Thus, two more cell types can be incorporated simultaneously into a construct.
This amplified integration possesses some outstanding advantages towards complex organ
manufacturing: (i) hierarchically organization of multiple population of cells and growth
factors in a more intricate physiologically mimicking geometry; (ii) simultaneously deposi‐
tion of one scaffold material, a vascular system with two main cell types, and one parenchy‐
mal cell type in a more elegant native tissue-specific phenotype; (iii) computer definition of
the fluid paths and macro/microstructures in a more patient specific manner; and (iv) spatial
distribution of multi-tissue boundaries and fluorescent biomarkers in a more controllable
pattern. This FLDM RP system makes it possible to partially control over the design, model‐
ing and fabrication of a highly hierarchical liver lobe like construct in a rapid, convenient,
and cost effective manner.
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Figure 8. A schematic description of the modeling and manufacturing processes of four liver lobe-like constructs with
a FLDM RP system developed in Tsinghua University, prof. XH Wang’ group [18].
6. Emphases to some technical specifications
Theoretically, RP technology is able to produce any required complex shape. The standard
modeling and deposition technologies enable the hybrid hierarchically ordered patterns to
be generated in an automatic, convenient, and inexpensive manner. Again, we use the liver
as an example. In a liver lobe at least 6 different cell types are structured as repeated units.
These units can achieve high oxygen exchange and nutrient supply for a mass of cells where
the cell sizes are in the range of ~20 µm. This geometry enables a high degree of processing
optimization, which provides the opportunity for RP designers and manufacturers to con‐
trol readily the distribution of different cells in a construct. Stimulated by this motivation,
many groups have tried different RP systems with only thin or quasi-3D cell containing
structures so far. Someone even claims to use scaffold free cell aggregates to print organs.
This has been proven to be a time-consuming process and cells can not find their respective
places in a complex organ without the support of scaffold materials.
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Different from all the existing techniques, the gelatine-based hydrogel has been explored ex‐
tensively as an internal scaffold material with the single/double syringe/nozzle RP techni‐
ques in the author’s own group Tsinghua University. Aqueous gelatin solution is an
amorphous natural hydrogel in which cells can be encapsulated, extruded and deposited at
desired positions [87-90]. This solution is flexible with a gelation temperature of 20℃ and
allow the diffusion of hydrophilic substrates. The sol-gel transform property makes it possi‐
ble to deposit the gelatin-based cell-laden hydrogel at a large range of temperature (from
20℃ to -30℃). However, this hydrogel is not stable at 37℃. The mechanical properties of the
gelatin-based hydrogels are notoriously inadequate and prohibit the use in stress-loaded im‐
plants. To improve the stability of the gelatin-based hydrogels, alginate and fibrinogen were
incorporated. Sodium alginate (composed of mannuronic and guluronic (G) dimmers) is a
biocompatible and biodegradable polymer, and has been widely used in cell encapsulation
technology, although the biocompatibility of the alginates in relation to their composition is
a matter of debate. Sodium alginate can be reversibly cross-linked by divalent cations, such
as Ca+2 and Mg+2, to form a relatively stable hydrogel. Fibrin, derived from blood fibrinogen,
is another natural biocompatible and biodegradable polymer, which has been widely used
as sealant and adhesive during surgery. With the catalyzing of thrombin smaller fibrinogen
molecules can polymerize to form a stable fibrin hydrogel.
In addition to being able to build complex structures with precision and accuracy, it is
equally important that the mechanical properties of the supporting materials are suitable for
the intended applications. A novel linear elastomeric polyurethane from soft polycaprolac‐
tone (PCL) and polyethylene glycol (PEG) segments, and hexamethylene diisocyanate (HDI)
chain extender has been synthesized in the authors’ own group and used as an external scaf‐
fold material. This PU possesses tunable biodegradability, excellent biocompatibility and
compatible mechanical properties with animal veins [91,92]. Long-term in vivo biocompati‐
bility and biodegradability of the PU have been proven with a rabbit model. It has success‐
fully repaired nerve and vein defects without any detected side effects, such as thrombosis,
inflammation, intimal hyperplasia, and calcification. The excellent mechanical properties, bi‐
ocompatibilities, adjust abilities and processing abilities have made this kind of polymer to
be outstanding from the other existing synthetic scaffold biomaterials, such as polyhydroxy‐
butyrate (PHB) [93], poly(D,L-lactic-co-glycolic acid) (PLGA) [94], and poly(tetrafluoroethy‐
lene) (PTFE) [95].
To date, the most widely recognized advantage of the RP technology (i.e. layered manufac‐
turing methodology) is the relative ease of automatically manufacture of complex geometric
shapes with heterogeneous structures composed of multi-material regions. Complex organ
manufacturing aims to automatically produce complex organs directly from CAD models
with high sophisticated RP techniques. Since the earlier concept of complex organ manufac‐
turing using both synthetic and natural scaffold biomaterials and multi-nozzle RP techni‐
ques was first introduced in 2007, the present technique was developed gradually [13-18].
As displayed in Figure 7D, the virtual elliptic construct with branched fluidic network has
been designed and fabricated according to a pre-defined CAD software. The integration of
the DLDM RP technique with the cell cryopreservation technique together with the mechan‐
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ically strong enough synthetic PU scaffold enables us to efficiently produce spatially hetero‐
geneous cell-laden tissue/organ substitutes that would otherwise be challenging to achieve
[61-64]. This integrated technique therefore has the potential to lead a big revolution in the
fields of tissue engineering and regenerative medicine.
It is expected that in the following several years these integrated RP technologies will see
their major break-through development stage and play a key role in complex organ manu‐
facturing area. With the proper integrations of biomaterials and enabling RP techniques, it is
possible for us to address all the challenges involved in complex organ manufacturing and
to make the realization of complex organ manufacturing both feasible and practical. These
proper integrations also benefit some of other related areas, such as high throughput drug
screening, stem cell differentiation induction, fluorescent dye discovering, energy metabolite
model establishing and cancer/stem cell behavior controlling.
7. Concluding remarks
The goal of complex organ manufacturing is to directly fabricate multiple cell types into an
organ substitute using a multiple nozzle RP system. Analogous to the process of building a
nuclear power plant, complex organ manufacturing requires the ability to control the posi‐
tions of many cell types, internal/external scaffold materials, and even cell growth factors on
the nano-, micro-, and macro-scales with respect to each others. The integrations of biomate‐
rials and RP techniques have significantly improved the ability to manufacture cell-laden
constructions with predefined geometries under the instructions of CAD models or medical
data (for example, patient-specific images). Especially, recent advances in DLDM and FLDM
RP techniques in Tsinghua University have leveraged these progresses. Although still at its
infant stages and associated with numerous problems, ever-increasing evidence supports
the intriguing hypothesis that the integrations of multiple biomaterials (including multiple
cell types) and multiple nozzle RP techniques will eventually change the traditional practi‐
ces and make the dreams of complex organ manufacturing come true. It is expected that in
the future, most of the reconstructive disciplines of complex organ manufacturing will be
fully revised by the development of new multiple nozzle RP systems with optimal safety,
easy manipulation ability and maximum reliability. Multiple nozzle RP techniques will un‐
doubtedly play an important role in the future complex organ manufacturing area. Cells in
the engineered construct will potentially behave as comfortably as in their natural in vivo
environment. Further studies are therefore needed to elucidate and determine the funda‐
mental structure-function relationships of diverse tissues in a complex organ, the nutrition
supply systems and the heterogeneous structural cues to promote full functional realization
in a complex organ. Ever increasing evidences have indicated that with the right integra‐
tions of biomaterials and RP techniques, a brand-new era of complex organ manufacturing
like the rising sun, is on the horizon.
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